Building Blocks

<p>Versatile small molecule scaffold</p>

<p>5-Chloro-[1,3]thiazolo[5,4-d]pyrimidine is a non-polar compound that is soluble in non-polar solvents. It reacts with 5-aminouracil to form the pentasulfide. This reaction can be followed by monitoring the change in fluorescence of the product as it cyclises to form a chloride. The reaction may also be monitored by measuring the release of phosphorous pentoxide gas from phosphoryl chloride. 5-Chloro-[1,3]thiazolo[5,4-d]pyrimidine has been used in fluorescence studies and cyclisation reactions.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>N-Cyclopropyl-benzylamine is a dopamine precursor that inhibits the activity of p-450 enzymes. It has been shown to be effective in clinical trials and is used as a model drug for other compounds with similar structures. N-Cyclopropyl-benzylamine irreversibly inhibits the activity of p-450 enzymes, but does not inhibit other cytochrome P450 enzymes such as CYP2D6 or CYP1A2. It has been shown to have antihypertensive effects in animal models and human pharmacokinetic studies, but no biological properties have been identified. N-Cyclopropyl-benzylamine can be found in rat liver microsomes and aminergic neurons.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>2-Bromobutyl acetate is an experimental chemical that has been used in organic synthesis. It is a dehydrogenase inhibitor, and its recycling properties have been shown in some experiments.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>5-Acetylfuran-2-carboxylic acid is a pharmaceutical compound that is synthesized by the acetylation of 5-acetylfuran. It can be used as a raw material for the synthesis of other pharmaceuticals, such as ferrocene and aliphatic alcohols. Acetylation can be carried out using acetic anhydride or acetyl chloride. This chemical has been shown to have high yield when synthesized in bulk quantities and can be easily made into polyalkylated compounds. The nature of this compound is not yet known.</p>

<p>6-Phenyl-pyrimidine-2,4-diol is a cyclobutane that can be found in acidic solutions. It can also be found as an enantiomeric mixture of the two stereoisomers, which are the result of a dimerisation reaction. The hydrated form of this molecule has been shown to react with nucleic acids and nucleobases. 6-Phenyl-pyrimidine-2,4-diol can be used as a precursor to form other molecules.</p>

<p>1-nitro-2-(prop-2-yn-1-yloxy)benzene (NPPB) is a p-glycoprotein inhibitor that blocks the efflux of anticancer drugs from cancer cells. It has been shown to inhibit the cytotoxicity of verapamil, which is a calcium channel blocker used in the treatment of high blood pressure and coronary artery disease. NPPB is also a modulator that inhibits multidrug resistance, which is the ability of cancer cells to resist chemotherapy. This drug has been shown to induce apoptosis in a dose dependent manner, which means that it kills cancer cells when they are exposed to higher doses. NPPB can be used as an anticancer drug in combination with other drugs to increase its effectiveness and reduce toxicity.</p>

<p>Naphthalen-2-ylpropanoic acid is a molecule that is used as an oral drug. It is a potentiator of opioid analgesics and has been shown to inactivate some types of bacterial cells. Naphthalen-2-ylpropanoic acid binds to the naphthol group of β-lactam antibiotics, which leads to their inactivation by covalent binding. This compound also inhibits the production of acetaminophen, which may be due to its inhibition of glutathione reductase enzymes. Naphthalen-2-ylpropanoic acid has been found to be safe for use in infants and children, as well as for adults, with no significant adverse effects observed at therapeutic doses.</p>